The estimated Net Worth of Wilfred E Jaeger is at least $134 Million dollars as of 2 July 2018. Wilfred Jaeger owns over 6,667 units of Nevro Corp stock worth over $31,402 and over the last 10 years he sold NVRO stock worth over $133,518,477. In addition, he makes $260,205 as Independent Director at Nevro Corp.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Sign up
Wilfred Jaeger NVRO stock SEC Form 4 insiders trading
Wilfred has made over 16 trades of the Nevro Corp stock since 2015, according to the Form 4 filled with the SEC. Most recently he bought 6,667 units of NVRO stock worth $113,339 on 2 July 2018.
The largest trade he's ever made was selling 393,468 units of Nevro Corp stock on 8 June 2015 worth over $18,862,856. On average, Wilfred trades about 42,050 units every 27 days since 2014. As of 2 July 2018 he still owns at least 6,667 units of Nevro Corp stock.
You can see the complete history of Wilfred Jaeger stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wilfred Jaeger biography
Dr. Wilfred E. Jaeger, M.D. is Independent Director of the Company. Dr. Jaeger was the co-founding partner of Three Arch Partners, a healthcare-focused investment, and has served as a Partner and Managing Member from 1993 to 2019. Prior to co-founding Three Arch Partners, Dr. Jaeger was a general partner at Schroder Ventures. Dr. Jaeger currently serves on the board of directors of Concert Pharmaceuticals, Inc., a public clinical stage biopharmaceutical company, and Neuronetics, Inc., a public medical device company, as well as numerous private companies. Dr. Jaeger received a B.S. in Biology from the University of British Columbia, an M.D. from the University of British Columbia School of Medicine and an M.B.A. from the Stanford Graduate School of Business. Jaeger is qualified to serve on our Board due to his investment experience, strategic leadership track record and service on other boards of directors of life sciences companies.
What is the salary of Wilfred Jaeger?
As the Independent Director of Nevro Corp, the total compensation of Wilfred Jaeger at Nevro Corp is $260,205. There are 14 executives at Nevro Corp getting paid more, with D.Keith Grossman having the highest compensation of $13,877,700.
How old is Wilfred Jaeger?
Wilfred Jaeger is 64, he's been the Independent Director of Nevro Corp since 2014. There are 3 older and 19 younger executives at Nevro Corp. The oldest executive at Nevro Corp is Frank Fischer, 78, who is the Independent Director.
What's Wilfred Jaeger's mailing address?
Wilfred's mailing address filed with the SEC is C/O NEURONETICS, INC, 3222 PHOENIXVILLE PIKE, MALVERN, PA, 19355.
Insiders trading at Nevro Corp
Over the last 10 years, insiders at Nevro Corp have traded over $298,472,982 worth of Nevro Corp stock and bought 312,708 units worth $8,709,518 . The most active insiders traders include Ali Behbahani, Holdings A/S Novo, and & Johnson Johnson & Johnson.... On average, Nevro Corp executives and independent directors trade stock every 18 days with the average trade being worth of $161,002. The most recent stock trade was executed by Shawn Mc Cormick on 7 June 2023, trading 7,500 units of NVRO stock currently worth $171,600.
What does Nevro Corp do?
headquartered in redwood city, california, nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. nevro has developed and commercialized the senza spinal cord stimulation (scs) system, an evidence-based neuromodulation platform for the treatment of chronic pain. the senza system is the only scs system that delivers nevro's proprietary hf10 therapy. the nevro® senza® scs system received ce mark in 2010, tga approval in 2011, fda approval in 2015, and is commercially available in europe, australia, and the united states.
What does Nevro Corp's logo look like?
Complete history of Wilfred Jaeger stock trades at Concert Pharmaceuticals Inc, Nevro Corp, and Neuronetics Inc
Nevro Corp executives and stock owners
Nevro Corp executives and other stock owners filed with the SEC include:
-
D.Keith Grossman,
Chairman of the Board, President, Chief Executive Officer -
Niamh Pellegrini,
Chief Commercial Officer -
Michael Carter,
Vice President - Global Sales -
Christopher Christoforou,
Vice President - Research and Development -
D. Keith Grossman,
Chairman, CEO & Pres -
Patrick Schmitz,
Vice President - Operations -
Kashif Rashid,
Chief Compliance Officer, General Counsel, Corporate Secretary -
Andrew H. Galligan,
Exec. Officer -
Kashif Rashid,
Gen. Counsel, Corp. Sec. & Chief Compliance Officer -
Roderick H. MacLeod,
Chief Financial Officer -
Elizabeth Weatherman,
Independent Director -
Kevin O'Boyle,
Independent Director -
Karen Prange,
Independent Director -
Michael DeMane,
Lead Independent Director -
Wilfred Jaeger,
Independent Director -
Shawn McCormick,
Independent Director -
Frank Fischer,
Independent Director -
Brad Vale,
Independent Director -
David Caraway,
Chief Medical Officer -
Donald Middlebrook,
Vice President - Clinical, Regulatory and Quality -
Juliet Cunningham,
Vice President - Investor Relations -
Lori Ciano,
Chief Human Resource Officer -
Roderick MacLeod,
Chief Financial Officer -
Dr. David Caraway,
Chief Medical Officer -
Lori M. Ciano,
Chief HR Officer -
Patrick Schmitz,
VP of Operations -
Jon R. Shear,
VP of Corp. Devel. -
Michael Collier Carter,
VP of Global Sales -
Julie D. Dewey,
Chief Corp. Communications & Investor Relations Officer -
Sridhar Kosaraju,
-
James Alecxih,
Vice President, Sales -
Lisa D Earnhardt,
Director -
Andre Walker,
Senior VP,Research&Development -
Ali Behbahani,
Director -
Kevin R Thornal,
President & CEO -
Rami Elghandour,
President -
Michael Enxing,
VP of Sales & Marketing -
Arch Management Iv, L.L.C.T...,
-
City Capital Llc Bay City C...,
-
Holdings A/S Novo,
10% owner -
Partners Ii Lp Amv,
-
City Capital Llc Bay City C...,
-
Nathan B Pliam,
Director -
& Johnson Johnson & Johnson...,
-
Balakrishnan Shankar,
VP, Operations -
Andrew H Galligan,
Chief Financial Officer -
Doug Alleavitch,
VP, Quality -
Kirt P Karros,
-
Christofer Christoforou,
SVP, Chief Operating Officer -
Greg Siller,
SVP & Chief Commercial Officer -
Richard B. Carter,
Chief Accounting Officer -
Susan E Siegel,